Offer - Urjas Oil for just ₹ 1
Xigduo XR 10/500 Mg Tablet is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Diabetes Type 2, Diabetes.
The correct dosage of Xigduo XR 10/500 Mg Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The most common side effects of Xigduo XR 10/500 Mg Tablet are Stomach Upset, Difficulty urinating. Apart from the aforementioned side effects, Xigduo XR 10/500 Mg Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Xigduo XR 10/500 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Xigduo XR 10/500 Mg Tablet's effect during pregnancy is Mild and Moderate while nursing. It is important to know if Xigduo XR 10/500 Mg Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Xigduo XR 10/500 Mg Tablet related warnings section.
Xigduo XR 10/500 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bladder Cancer, Kidney Disease, Congestive Heart Failure (CHF) are examples of such conditions. Other contraindications of Xigduo XR 10/500 Mg Tablet have been discussed in the sections ahead.
Drug reaction of Xigduo XR 10/500 Mg Tablet with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Xigduo XR 10/500 Mg Tablet is safe while driving, and is is addictive in nature.
Xigduo XR 10/500 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Xigduo XR 10/500 Mg Tablet safe for pregnant women?
Pregnant women can consume [medicine]. Though Xigduo XR Tablet has mild side effects when taken during pregnany
Is the use of Xigduo XR 10/500 Mg Tablet safe during breastfeeding?
Xigduo XR Tablet may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Xigduo XR Tablet, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Xigduo XR Tablet.
What is the effect of Xigduo XR 10/500 Mg Tablet on the Kidneys?
Xigduo XR Tablet does not damage the kidneys.
What is the effect of Xigduo XR 10/500 Mg Tablet on the Liver?
Xigduo XR Tablet is completely safe for the liver.
What is the effect of Xigduo XR 10/500 Mg Tablet on the Heart?
There are no any side effects of Xigduo XR Tablet for the heart.
If you are suffering from any of the following diseases, you should not take Xigduo XR 10/500 Mg Tablet unless your doctor advises you to do so -
Is this Xigduo XR 10/500 Mg Tablet habit forming or addictive?
No, there is no any evidence that Xigduo XR 10/500 Mg Tablet is addictive.
Interaction between Food and Xigduo XR 10/500 Mg Tablet
There isn't any research available on the side effects of taking Xigduo XR 10/500 Mg Tablet with food.
Interaction between Alcohol and Xigduo XR 10/500 Mg Tablet
Consult your doctor before consuming alcohol while taking Xigduo XR 10/500 Mg Tablet as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826